Trinity Biotech Announces Strategic Collaboration with Medical Artificial Intelligence Company PulseAI

May 16, 2024

https://www.globenewswire.com/news-release/2024/05/16/2883525/8624/en/Trinity-Biotech-Announces-Strategic-Collaboration-with-Medical-Artificial-Intelligence-Company-PulseAI.html

DUBLIN, Ireland, May 16, 2024 (GLOBE NEWSWIRE) — Trinity Biotech plc (Nasdaq:TRIB) a commercial stage biotechnology company focused on human diagnostics and diabetes management solutions, including wearable biosensors, today announced a strategic collaboration with medical artificial intelligence (“AI”) company PulseAI to enhance the Company’s recently acquired continuous glucose monitor (CGM) biosensor technology.

Read more at globenewswire.com

NASDAQ and NYSE quotes and data are delayed 15 minutes unless indicated otherwise. Market data and exchange information are provided for informational purposes only and is not intended for trading purposes. Neither 24/7 Market News Editors, 247 Market News, or data and content providers shall be liable for any errors or omissions, delays, misquotes or other market information relayed in any press materials. You should Use Realtime data to conduct due diligence before investing or trading, and trading in any stock is risky you could lose all your money.